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Sex-speciﬁc response to 17β-estradiol
Estrogen receptor
Distribution of ERα and ERβ in male and
female growth plate chondrocytesBothmale and female rat growth plate chondrocytes express estrogen receptors (ERs); however 17β-estradiol (E2)
inducesmembrane responses leading to activation of phospholipase A2 (PLA2), phospholipase C (PLC), prostaglan-
din E2 (PGE2) production, protein kinase C (PKC), and ultimately mitogen protein kinase (MAPK) only in female
cells. This study investigated if these sex-speciﬁc responses are due to differences in the actual ERs or in down-
stream signaling. Western blots and ﬂow cytometry of costochondral cartilage resting zone chondrocytes (RCs)
showed 2–3 timesmore ERα in plasmamembranes (PMs) from female cells thanmale cells. Tunicamycin blocked
E2-dependent ER-translocation to the PM, indicating palmitoylation was required. Co-immunoprecipitation
showed E2 induced complex formation between ER isoforms only in female RCs. To examine if the lack of response
in PKC and PGE2 inmales is due to differences in signaling,we examined involvement of ERs and the role of PLC and
PLA2. Selective ERα (propylpyrazole triol, PPT) and ERβ (diarylproprionitrile, DPN) agonists activated PKC in fe-
male RCs only. The PLC inhibitor, U73122 blocked E2's effect on PKC and the cytosolic PLA2 inhibitor, AACOCF3
inhibited the effect on PGE2 in female RCs, conﬁrming involvement of PLC and PLA2 in the mechanism. The PLC
activator, m-3M3FβS activated PKC and PLAA peptide increased PGE2 levels in male and female RCs, showing
that the signaling pathways are present. These data indicate that differences inmembrane ER amount, localization,
translocation and interaction are responsible for the sexual dimorphic response to E2.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Longitudinal growth is regulated by the activity of chondrocytes in
the epiphyseal growth plates of long bones, including proliferation, dif-
ferentiation, and apoptosis. Many hormones and growth factors play a
role in the regulation of this process. Among these, sex steroids are of
crucial importance, especially during puberty [1]. Estrogens are involved
in the initiation of the pubertal growth spurt and in fusion of the growth
plate at the end of puberty in both boys and girls. The reasons for the
different effects of estrogens during puberty are not well understood.
In vitro studies examining the effect of estradiol on growth plate
chondrocytes have provided conﬂicting information. 17β-Estradiol at
physiological concentrations (10−11 to 10−12 M) has been reported
not to affect proliferation, viability or synthesis of type X collagen in pri-
mary cultures of resting, proliferative or hypertrophic chondrocytes in
one set of experiments [4]; to stimulate chondrocyte proliferation in
other studies [5,6]; and to inhibit chondrocyte proliferation in yetngineering, Georgia Institute of
3, USA. Tel.: +1 404 385 4108;
. Boyan).
rights reserved.other studies [7–9]. One possibility is that the systemic levels of the
hormone, and presumably its concentration in the tissue, are factors.
Levels of systemic estrogens are important variables, but the num-
ber and type of estrogen receptors (ERs) are also critical determinants
of growth plate response to the hormone [2,3]. Both ERα and ERβ are
present in growth plates of both males and females at the mRNA and
protein level in several species, including rat, rabbit, and human
[10–13], indicating that estrogens can directly regulate the tissue in ad-
dition to their indirect effects via growth hormone [14–18]. Moreover,
experiments using fetal rat and neonatal mouse bone organ cultures
show that growth plate development is regulated in a sex-speciﬁcman-
ner [19]. The results suggested that the sexual dimorphism was at the
cellular level. Although the binding afﬁnity of E2 for ERs in growth
plate chondrocytes was comparable in cells from both male and female
rats, female cells had greater numbers of receptors than male cells [20].
While receptor number could contribute to differences in response
rate, it does not explain the marked differences in biological responses
observed betweenmale and female cells.Whereas E2 caused an increase
in chondrocyte differentiation in female cells, it did not do so in male
cells [7]. This effect of E2 was stereospeciﬁc, indicating that it was recep-
tor mediated. However, themechanism involved differed from thatme-
diating the effect of E2 on chondrocyte apoptosis, whichwas the same in
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brane associated signaling in the sex-speciﬁc responses. E2 caused
rapid increases in Ca++ ion transport [22] and activation of protein ki-
nase C (PKC) [23] and phospholipase A2 [24] in female chondrocytes
but not in male cells. Importantly, these effects of E2 could also be
seen in cells treated with E2-conjugated to bovine serum albumin
(E2-BSA), which can't pass the plasma membrane, but did stimulate
PKC. Moreover, inhibition of PKC signaling blocked the downstream ef-
fect of E2 on chondrocyte differentiation [25]. Additionally, neither
diethylstilbesterol nor ICI 182780, which are known to act via the
nuclear ER, had an effect on the membrane associated response [25].
We hypothesized that ERs resident in the plasma membranes of
growth plate chondrocytes might be responsible for the differential re-
sponses seen inmale and female cells. ERα [26,27] and ERβ [28–30] are
the products of separate genes. In many cells, they coexist either as
homodimers or as heterodimers [31,32]. Recent evidence indicates
that there are speciﬁc actions of E2 that can be attributed to one receptor
but not the other [33,34]. This is supported by in vitro studieswhere es-
trogen analogs have been shown to preferentially activate the two ERs
[35]. These observations, coupled with the fact that ERβ can form
homodimers and heterodimers with ERα in vitro [31,32], suggest that
the activity of estrogens may depend on whether a cell contains ERα,
ERβ, or both.
While it is known that ERα and ERβ are both present in male and fe-
male cells, it is not known if they are differentially expressed or activated.
It is also not known if they are transported to themembrane in a compa-
rable manner. Of particular importance is if the membrane associated
signaling pathways needed to mediate the downstream responses to
E2 are present inmale growth plate chondrocytes. In this study, we com-
pared the expression and subcellular localization of ERα and ERβ inmale
and female rat costochondral growth plate chondrocytes; we deter-
mined if their presence in the membrane involved palmitoylation as
has been shown in other systems; and we investigated differences in
the potential downstream signaling pathways.
2. Material and methods
2.1. Reagents
17β-Estradiol (E2); methyl-β-cyclodextrin (β-CD), which depletes
lipid rafts and alters the caveolar microenvironment [36,37]; the phos-
pholipase C (PLC) inhibitorU73122 [38]; and the PLA2 inhibitor AACOCF3
[39] were purchased from Sigma Chemical Co. (St. Louis, MO). The
ERα-selective agonist propyl pyrazole triol (PPT) [40–42]; the PLC ago-
nist m3M3FβS [43]; and the ERβ-selective agonist diarylpropionitrile
(DPN) [40–42] were obtained from Tocris Cookson Inc. (Ellisville, MO).
Tunicamycin, an inhibitor of palmitoylacetyltransferase [44], was pur-
chased from EMD Chemicals, Inc. (San Diego, CA). ERαmonoclonal anti-
body (ab16460) and ERβ monoclonal antibody (ab16813) were
purchased from Abcam (San Francisco, CA). A polyclonal antibody to
caveolin-1 (Cav-1) was purchased from Santa Cruz Biotechnology
(sc-894, Santa Cruz, CA). PKC BioTrak assay kits were obtained from GE
Lifesciences (Piscataway, NJ) and phenol red-free Dulbecco's modiﬁed
Eagle medium (DMEM) was obtained from GIBCO-BRL (Gaithersburg,
MD). The protein content of each sample was determined using the
bicinchoninic acid (BCA) protein assay kit [45] obtained from Pierce
Chemical Co. (Rockford, IL). [32P]-ATP was obtained from Perkin Elmer
(Melville, NY).
2.2. Chondrocyte Cultures
The culture system used in this study has been described in detail
previously [46]. Chondrocytes were isolated from the resting zone carti-
lage of the costochondral junction of 150 g male and female Sprague–
Dawley rats, plated at an initial density of 10,000 cells/cm2, and
maintained in phenol red-free DMEM containing 10% fetal bovineserum (FBS) and 50 μg/ml ascorbic acid. The medium was replaced
after 24 h and then every 48 h until cultures reached conﬂuence. Fourth
passage cells were used for all experiments based on previous studies
showing that these cells preserve their chondrocyte phenotype as well
as their differential responsiveness to vitamin Dmetabolites at this pas-
sage [47]. Conﬂuent fourth passage male and female cells in 24 well
plates were treated for 90 min with 0.5 ml of ethanol at the highest
concentration used in experimental cultures or experimental media
(phenol red-free DMEM+10% FBS+appropriate concentration of E2).
2.3. ER expression and subcellular localization
2.3.1. Plasma membrane and caveolae isolation
Plasma membranes were isolated using a detergent-free method as
described previously [48]. Conﬂuent, fourth passage resting zone
chondrocytes isolated from female and male rats were treated with ei-
ther 10−7 M E2 or vehicle for 90 min. The cell layers were washed
two times with phosphate buffered saline (PBS) to remove any residual
medium and cells were harvested by scraping using isolation buffer
(0.25 M sucrose, 1 mM EDTA, 20 mM Tricine, pH 7.8). Cells were ho-
mogenized using a tissue grinder and the homogenate centrifuged at
3500 rpm for 10 min to pellet large debris including the nucleus, mito-
chondria, and endoplasmic reticulum. The supernatant was collected
and layered on 30% Percoll in isolation buffer (GE Healthcare,
Piscataway, NJ). Plasma membranes were collected from the samples
by centrifuging at 30,500 rpm for 30 min and removing the visible
band in themiddle of the gradient column. The plasmamembrane frac-
tionwas then layered over a 10–20%OptiPrep gradient (Sigma-Aldrich),
and the gradient was centrifuged at 26,500 rpm for another 4 h. Plasma
membrane sub-fractions were collected from the top to the bottom of
the tube, which resulted in isolation of 15 fractions. Caveolae were ob-
served as an opaque band, which was collected in fraction 3.
Western blots were used to determine if ERα and/or ERβ were
present in whole cell lysates and the distribution of the ER isoforms
in plasmamembranes and caveolae in the male and female cells. Plas-
ma membranes, the caveolae fraction and the nuclear fraction were
separated on 4-20% gradient acrylamide gels. Blots of the gels were
probed with either the mouse monoclonal antibody against ERα or
the mouse monoclonal antibody against ERβ. In addition, blots were
probed using a polyclonal antibody to caveolin-1 (Cav-1). Immunore-
active bands were visualized using goat anti-mouse horseradish
peroxidase-conjugated secondary antibodies (Bio-Rad, Hercules,
CA). The Super Signal West Pico Chemiluminescent System (Thermo
Fisher Scientiﬁc) was used to treat the membrane and then imaged
with the VersaDoc imaging system (Bio-Rad).
2.3.2. Palmitoylation
To assess the role palmitoylation in localizing ERα and ERβ to the
plasma membrane as well as the role of E2 in regulating ERα and ERβ
palmitoylation, male and female cultures were pre-incubated with
30 μM tunicamycin for 2 h. The cells were then treated with 10−7 M
E2 for 90 min. Plasmamembranes were isolated and analyzed as above.
2.3.3. Receptor complex formation
To determine if the ER isoforms formed complexes in response to E2,
fourth passage chondrocytes from female rats were treated with and
without 10−7 M E2 for 90 min. At harvest the cell layers were washed
with PBS and the cells were lysed and sonicated in RIPA buffer (50 mM
Tris–HCl, 150 mM NaCl, 5 mM disodium EDTA, 1% Nonidet P-40)
containing 100 mM NaF, protease inhibitor cocktail (Sigma-Aldrich)
and 1 mM phenylmethylsulfonyl ﬂuoride (PMSF). Protein samples
were mixed with anti-ERα antibody and incubated at 4 °C overnight
with continuous agitation. Immunoprecipitation was measured in pro-
tein samples using a commercially available Dynabeads® Protein kit fol-
lowing the manufacturer's directions (Invitrogen, Grand Island, NY). In
order to lower the background in the images, a ONE-HOUR IP-Western
Fig. 1. Difference in the amount and subcellular localization of ERα and ERβ betweenmale and female chondrocytes. Subcellular localization of ERα in female resting zone chondrocytes (A), or
male resting zone chondrocytes (B). Subcellular localization of ERβ in female resting zone chondrocytes (C), or male resting zone chondrocytes (D). Whole cell lysates (WCL), plasma mem-
branes (PM), caveolae fraction (F3), and nuclear fraction (NF) were isolated and subjected to Western blot. Female cultures were pre-incubated for 30 min with 5 mM
methyl-β-cyclodextrin (β-CD) and then treated with 10−7 M E2 for 90 min. PKC speciﬁc activity was measured in cell layer lysates. Values are the mean±SEM for six independent cultures
for each variable. *Pb0.05, treatment vs. control, ^Pb0.05, E2+ β-CD vs. E2 alone.
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subjected to Western blot analysis.2.3.4. Receptor number
The number of the ERs on the plasmamembrane and intracellularly
was evaluated by ﬂow cytometry using the Quantum Simply Cellular
Microbeads Kit (Bangs Laboratories, Inc. Fishers, IN). This kit provides
a method for the evaluation of the number of molecules of antibody
per cell. Brieﬂy, this kit is comprised of populations of uniform
cell-sized microspheres with different calibrated binding capacities of
goat anti-mouse IgG (FC-speciﬁc) on their surface. The kit includes 4
coated populations, each with different antibody binding capacity
(ABC) for mouse monoclonal antibodies, and 1 blank population with
no speciﬁc binding capacity for mouse IgG. When the bead populations
are labeled in the samemanner as the cells to be analyzed, they provideFig. 2. Difference in ERα content betweenmale and female chondrocytes. Flow cytometry show
(plasma membrane and nuclear receptors) in permeabilized (B). Values are the mean±SEM fa means of constructing a QuickCal® calibration curve (ABC values ver-
sus ﬂuorescence intensity), from which samples may be analyzed.
The number of ERα cell surface receptors was determined by incu-
bating male and female cell suspensions (5∗105 cells) for 30 min in
150 μl 1% bovine serum albumin (BSA) with a 1:50 dilution of the
ERα monoclonal antibody. Cells were then washed with 1 ml 1% BSA,
centrifuged for 5 min at 1000 rpm, and resuspended in 150 μl 1% BSA
containing a 1:500 dilution of goat-anti mouse antibody conjugated to
Alexa Fluor® (Invitrogen, Grand Island, NY) for 30 min in the dark.
Cells were centrifuged at 1000 rpm for 10 min and resuspended in
300 μl PBS. After collecting the cells by ﬁltration, samples were ready
for analysis.
To determine the total number of receptors (surface and cytoplas-
mic), cells were ﬁxed by incubating with 4% paraformaldehyde in PBS
for 20 min at 4 °C. Then cells were collected by centrifugation at
1000 rpm for 10 min and resuspended in permeabilization solutioning plasmamembrane ERα content in non permeabilized cells (A), and total ERα number
or six independent cultures for each variable. *Pb0.05, female vs. male.
Fig. 3. Palmitoylationof themembrane receptor is required for E2-dependentPKCactivity only in female chondrocytes. Female cellswere either treated for 90 minwith10−7 ME2 alone orwith
30 μMtunicamycin for 2 h and then treatedwith10−7 ME2 for 90 min. Presence of ERα and ERβ inwhole cell lysates andplasmamembranes of female chondrocytes (A) ormale chondrocytes
(B) was examined byWestern blot.
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abilized cells were incubated with the primary antibody and further
processed as described above.Microspheres (50 μL per tube)were incu-
bated with the secondary antibody, washed and further processed on
the ﬂow cytometer under the same conditions as the samples.
2.4. Signaling pathways
2.4.1. Protein kinase C activity
Conﬂuent fourth passage male and female cells in 24 well plates
were treated for 90 min with 0.5 ml of ethanol at the highest concen-
tration used in experimental cultures or experimental media (phenol
red-free DMEM+10% FBS+10−7 to 10−10 M E2). To determine
which ERs were involved in this pathway, male and female cultures
were treated for 90 min with 10−7 to 10−9 M ERα-selective agonist
PPT or ERβ-selective agonist DPN, respectively. To determine if the
increase in PKC was caveolae dependent, female cultures were
pre-incubated for 30 min with 5 mM methyl-β-cyclodextrin (β-CD)
[36], and then treated for 90 min with 10−7 M E2.
We previously showed that phosphatidylinositol-speciﬁc PLC medi-
ated the rapid increase in E2-dependent PKC [25]. To establish if PLC also
plays a role in the increase in PKC at 90 min, conﬂuent cultures of female
cells were treated with E2±the PLC inhibitor U73122. To determine if
the downstream signaling pathway was functional in male cells, maleFig. 4. ERαwas immunoprecipitated and subjected to Western blot. The membranes were incub
group (10−7 M E2 for 90 min).and female cells were treatedwith PLC activatorm-3M3FβS and PKC ac-
tivity was measured. After the incubation period, cell layers were
washedwith PBS to remove any excess medium and then lysed in solu-
bilization buffer (50 mM Tris–HCl, pH 7.5, 150 mM NaCl, 5 mM EDTA,
1 mMPMSF and 1%NP-40). 25 μl of the cell lysates was assayed for pro-
tein content [45]. PKC activity was measured in cell lysates using a kit
following the manufacturer's directions (Amersham Bioscience). This
kit is optimized for measurement of phospholipid and Ca2+-dependent
PKC [49,50].
2.5. Regulation of PGE2 release
PGE2 production is a downstream consequence of PLA2 activation
and can activate the PKC signaling pathway leading to ERK1/2 activation
[51]. To determine if PGE2 release into the medium is produced in
response to E2, female cells were pre-incubated for 30 min with
10−6–10−5 M of the PLA2 inhibitor AACOCF3, and then cells were
treated with 10−7 M E2 for 90 min. Male and female cells were also
treated for 30 min with 10−6–10−5 M PLAA peptide, which activates
PLA2 [52]. At the end of the incubation, the media were acidiﬁed and
PGE2 was measured using a commercially available kit (Prostaglandin
E2 [125I]-RIA kit, NEK020001K, Perkin Elmer, Waltham, MA). PGE2
data were normalized to total DNA (Quant-iT™ PicoGreen® dsDNA
Assay kit, P11496, Invitrogen).ated with anti-ERα and anti-ERβ antibodies. C: control group (with vehicle only), T: treated
Fig. 5. Effect of PPT and DPN on PKC speciﬁc activity in resting zone chondrocytes. Conﬂuent fourth passage female andmale chondrocytes were treated for 90 min with 10−7 to 10−9 M PPT
(A) or 10−7 to 10−9 MDPN (B). PKC speciﬁc activitywasmeasured in cell layer lysates. Values are themean±SEM for six independent cultures for each variable. *Pb0.05, treatment vs. control
at each time point.
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For each experiment, each value represents the mean±the standard
error of themean (SEM)of the cell layers of six independent cultures. Sta-
tistical signiﬁcance was determined by analysis of variance (ANOVA).
Pb0.05 was considered signiﬁcant. Each experiment was repeated two
or more times to ensure the validity of the data. The data represented
are from a single representative experiment.
3. Results
3.1. Membrane ER localization
Western blots of the cell lysates demonstrated that ERαwas present
in female and male resting zone chondrocytes (data not shown). The
nuclear fraction from both cell types exhibited all three ERα isoforms:
ERα68, ERα46 and ERα36 (Fig. 1A,B). Plasma membranes from female
chondrocytes had all three isoforms, but male cells lacked ERα36. This
was also the case for caveolae. ERβ59 was present in plasma mem-
branes and nuclear fraction from female andmale cells andwas present
in caveolae from female cells but not male cells (Fig. 1C,D).
Sex-speciﬁc differences in the amount and distribution of ERαwere
conﬁrmed by ﬂow cytometry. There wasmore than twice asmuch plas-
mamembraneERα in non-permeabilized female cells than inmale cells.
Total ERα in permeabilized cells was not statistically different, howeverFig. 6. Activation of PKC by E2 is dependent onPLC signaling. Conﬂuent, fourth passage resting z
10−6–10−5 M PLC inhibitor U73122 (A) or 10−6–10−5 M PLC activatorm-3M3FβS (B). *Pb0.0
17β-estradiol.(Fig. 2A,B). Interestingly, the percentage of positive cells was not signif-
icantly different in both permeabilized and non-permeabilized female
and male cells.
3.2. Effect of E2 on ER localization
Tunicamycin reduced the amount of ERα68 in whole cell lysates of
female chondrocytes but had no effect on the male cells (Fig. 3A,B). E2
caused an increase in plasma membrane ERα46 and ERα36, as well as
ERβ59 in female cells, all of which were reduced by pretreatment
with tunicamycin. In contrast, E2 reduced the levels of ERα68, ERα46
and ERβ59 in the plasma membranes from male cells and this was un-
affected by tunicamycin treatment. These observations were conﬁrmed
by co-immunoprecipitation of ERα. Treatment of female chondrocytes
for 90 min with E2 increased the amount of ERα68, ERα46 and ERβ59
that was present in the immunoprecipitates, but inmale cells, the levels
of all three isoforms were reduced (Fig. 4).
3.3. Role of ERs and membrane associated signaling
Intact caveolae were required for E2 activation of PKC in female
cells. Treatment with methyl β-cyclodextrin blocked the stimulatory
effect of the hormone (Fig. 1E).
Both ERα and ERβ were involved in the E2-dependent activation of
PKC in female cells. Treatment of the cells with the ERα agonist PPTone cells from female rats (A,B) ormale rats (B)were treated for 90 minwith 10−7 ME2±
5, treatment vs. control, ^Pb0.05, E2+U73122 vs. E2 alone at a particular concentration of
Fig. 7. Production of PGE2 by E2 is dependent on PLA2 signaling. Conﬂuent, fourth passage resting zone cells from female rats (A,B) or male rats (B) were treated for 90 minwith 10−7 M E2±
10−6–10−5 M cytosolic PLA2 inhibitor ACCOCF3 (A) or 10−6–10−5 M PLA2 activator PLAA peptide (B). *Pb0.05, treatment vs. control, ^Pb0.05, E2+ACCOCF3 vs. E2 alone at a particular
concentration of E2.
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effect on PKC as E2. In contrast, activation of ERα or ERβ using the
respective agonists had no effect on PKC in male cells.
Inhibition of PLC blocked the stimulatory effect of E2 on PKC in the
female cells, even at 90 min (Fig. 6A). Conversely, the PLC activator
m-3M3FβS induced an increase in PKC activity in the female cells;
male cells also responded to the PLC activator with an increase in PKC,
but the effect was seen only at the highest concentration (Fig. 6B).
PGE2 production in response to E2 was blocked by the PLA2 inhibitor
AACOCF3 (Fig. 7A). Activation of PLA2with PLAA also caused an increase
in PGE2 release in the female cells; male cells exhibited an increase in
PGE2 release when treated with PLAA, but the stimulatory effect was
less robust than was observed in the female cells (Fig. 7B).
4. Discussion
This study provides evidence that the sex-speciﬁc difference in E2-
dependent membrane-associated signaling in male and female growth
plate chondrocytes is due to differential regulation of ER isoforms in
the plasmamembrane and speciﬁcally, in the caveolae.Whereas plasma
membranes and caveolae isolated from female cells possess ERα68,
ERα46 and ERα36 as well as ERβ59, plasma membranes from male
cells lack ERα36. Moreover, caveolae from male cells lack both ERα36
and ERβ59. Caveolae are critical to the ability of E2 to activate rapid
PKC signaling in the female cells, as evidenced by the loss of an E2 effect
when caveolae were disrupted by treatment with β-cyclodextrin.
We did not speciﬁcally knockdown ERα36 or ERβ59, but our results
strongly implicate both receptors in the failure of male cells to respond
to E2. Male caveolae lack both isoforms but possess ERα68 and ERα46.
Although agonists for both ERα and ERβ activated PKC in female
chondrocytes, neither agonist was able to do so in male chondrocytes,
despite the presence of two ERα isoforms as well as evidence compo-
nents of the signalingpathways involved in PKC activationwere present
and could be stimulated to the same extent as in female cells.
ER trafﬁcking may be an important variable in the differential re-
sponse of male and female chondrocytes to E2 as well. Others have
shown that palmitoylation is required for the plasmamembrane associ-
ation of ERs [44,53]. This was the case for female chondrocytes in the
present study. E2 increased the association of ERswith the plasmamem-
brane, particularly ERα46, ERα36 and ERβ59 whereas tunicamycin re-
duced the association of all three ERα isoforms and ERβ59 with theplasma membrane. In male cells, however, E2 caused a marked reduc-
tion in the association of ERα68, ERα46 and ERβ59 with the plasma
membrane. Why the receptor trafﬁcking in the male cells was contra
to that of the female cells is not clear. In female cells, E2 elicits formation
of a multi-receptor complex that involves both ERα and ERβ, but this is
not the case for male cells, suggesting that a scaffolding unit may be
absent. In other studies, caveolin-1 provides scaffolding for ER transloca-
tion to the plasmamembrane [37,54,55] and palmitoylation is required
for caveolin-1 to interact with the plasmamembrane [56]. This suggests
that a difference between male and female cells may be related to the
palmitoylation mechanism. It is also possible that E2 treatment in male
cells may lead to ER translocation to the nucleus.
Our results support our previous study indicating that female cells
may have more ERs than male cells [20] and show that it is speciﬁcally
the pool of ERs that are on the surface of the cell that contribute to this
increase. The percentage of positive female cellswas not signiﬁcantly dif-
ferent than the percentage of positive male cells in non-permeabilized
cells, although the total number of ERα on the surface was signiﬁcantly
higher in female cells. This is in agreement with our previous study,
which showed that there was no difference in E2-binding afﬁnity be-
tween females and males, but females had more receptors [20]. No dif-
ferences in total ERα number were found when assessing ERα content
of permeabilized cells whereas ERα content of non-permeabilized
cells, i.e., the cell surface, was more than two times greater in female
cells. This is an important observation given the fact that ERα36 was
present only on the plasma membranes of female cells, whereas all
other isoforms of ERα as well as ERβ59 were present on the plasma
membranes of male cells. While this strongly supports the hypothesis
that ERα36 plays a critical role, it is not yet deﬁnitive proof. However,
recent studies in our lab examining the role of ERα36 in E2 dependent
activation of PKC in breast cancer cells showed that speciﬁc antibodies
to this isoform blocked the stimulatory effect of the hormone [57].
E2 activates PKC in growth plate chondrocytes via two signaling
pathways, PLC and PLA2. Our results indicate that the failure of male
cells to respond to E2 is not due to an intrinsic defect in either pathway.
Activation of PLC bym-3M3FβS could be achieved to the same extent in
male and female cells. Similarly, both male and female cells were capa-
ble of generating PGE2 when PLAA was used to activate PLA2. The effect
of PLAAwas less robust inmale cells, raising the possibility that the PLA2
pathway was reduced in some manner, but it is difﬁcult to draw too
many conclusions given the fact that PGE2 production is a downstream
1171K.B.Y. Elbaradie et al. / Biochimica et Biophysica Acta 1833 (2013) 1165–1172surrogate for the enzyme itself. These data do show that the difference
in response occurs upstream from the enzymes triggering the signaling
pathways and supports the conclusion that the difference is at the re-
ceptor level.
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